Canada: Patent

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

AI has revolutionized the entertainment and gaming industry and has a multitude of uses.

L'IA a profondément transformé le secteur du divertissement et des jeux vidéo, et ouvre la voie à des utilisations multiples. Dans les jeux vidéo, l'IA permet de créer des effets spéciaux améliorés...

On April 14, 2025, the Federal Court of Canada issued a decision that serves as a reminder of the potential consequences of failing to manage intellectual property diligently within large infrastructure projects.

There's a new comeback story in town, and it's about as dramatic as a Snyder Cut reveal. Mattel has successfully clawed back the lucrative rights to make DC-themed action...

You may be interested in intellectual property (IP) license agreements if you're a creator or business looking to monetize your work or if you're seeking to utilize someone else's intellectual property.

In today's rapidly evolving digital landscape, data has emerged as one of the most valuable assets for businesses, driving innovation in artificial intelligence (AI) and data analytics.

On February 26, 2025, the Patent Appel Board was scheduled to hear submissions whether Canadian Patent Application No. 3,137,161 can comply with the formalities of the Patent Act and Rules.

On July 17, 2024, the Canadian Intellectual Property Office (CIPO) launched a new electronic system and portal, MyCIPO Patents, as part of its Next Generation Patents initiative.

In October 2019, amendments to the Patent Act (R.S.C., 1985, c. P-4) were made introducing the Due Care standard in order to satisfy Canada's obligations under the Patent Law Treaty...